Nowadays, IDH1/2 mutational status, rather than the subtypes described above, is the routine diagnostic molecular marker to differentiate among glioblastoma tumors, defining an IDH wild-type or mutant genotype [1]. The gene discussed is IDH1; the disease is glioblastoma.